Core One Labs is a biotech company focused on bringing psychedelic medicine to market through novel delivery systems (patent pending), psychedelic assisted psychotherapy and psilocybin manufacturing.

.

Stock information

Contact Information

Website: https://core1labs.com/

Contact Email:info@core1labs.com

Corporate Presentation Link: click here

Latest Core One Labs Inc News

Core One Labs Applauds TheraPsil on Its Submission to Health Canada

Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN: A3CSSU) (the “Company”) a research and technology company focused in life sciences and on ...

Core One Labs’ Clinics Submit Application to Treat Patient With Psilocybin Psychedelic-Assisted Therapy

Core One Labs Inc. (CNSX:COOL.CN), (OTC:CLABD), (Frankfurt: LD6, WKN: A3CSSU) (the “Company”) a research and technology company focused in life sciences and on bringing psychedelic ...

Core One Labs to Move Its Psychedelic Formulations for the Treatment of Stroke and Depression Toward Clinical Development

Core One Labs Inc. (CNSX:COOL.CN), (OTC:CLABD), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”) is pleased to announce that the scientific team of its ...

Core One Labs’ Virtual Town Hall Reveals Company is Nearing Production of Biosynthesized Psilocybin: Breakthrough In the Psychedelic Space Expected Upon Successful Completion

Core One Labs Inc. (CNSX:COOL.CN), (OTC:CLABD), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”) is a research and development company focused on bringing psychedelic ...

Core One’s Dr. Robert E.W. Hancock to Host Virtual Townhall Webcast and Present on Proprietary Biosynthesized Psilocybin Wednesday, August 4, 2021

Core One Labs Inc. (CNSX:COOL.CN), (OTC:CLABD), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”) is pleased to announce that Dr. Robert E.W. Hancock, the ...

Core One Labs’ Akome Seeks to Revolutionize Treatment of Parkinson’s Disease and Submits Application to Protect IP

Core One Labs Inc. (CNSX:COOL.CN), (OTC:CLABD), (Frankfurt: LD6, WKN: A3CSSU) (the “Company”) is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. (“Akome”) ...